Natsumi Takeyama
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
Journal: Frontiers in plant science
Published: November 22, 2023
A Heterodimeric Antibody Fragment for Passive Immunotherapy Against Norovirus Infection.
Journal: The Journal of infectious diseases
Published: November 27, 2019
Plant-based vaccines for animals and humans: recent advances in technology and clinical trials.
Journal: Therapeutic advances in vaccines
Published: December 16, 2015
Innate lymphoid cells regulate intestinal epithelial cell glycosylation.
Journal: Science (New York, N.Y.)
Published: September 13, 2014
RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds.
Journal: Plant cell reports
Published: July 13, 2013
MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
Journal: Journal of proteome research
Published: June 15, 2013
Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.
Journal: Plant biotechnology journal
Published: November 02, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026